The first 4D Molecular Therapeutics trade was made in Q3 2022. Since then Steven Cohen bought shares four more times and sold shares on four occasions. The investor sold all their shares in Q4 2024 and doesn't own any shares in 4D Molecular Therapeutics anymore.